CROSSROADS STRATEGIES, LLC

Lobbying for NOVAVAX, INC. · biotechnology company

Filing 2nd Quarter - Termination

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 20, 2025

Income

$20,000.00

What the client paid this registrant for the period.

Client based in

Maryland

Representation ended

Apr 30, 2025

The registrant reported terminating its work for this client.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 3

Health Issues

Issues related to COVID-19 vaccines.

Budget/Appropriations

FY2025 Budget Reconciliation Process; all bio-pharmaceutical related provisions.

Trade (domestic/foreign)

Issues related to tariffs.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.